Zephyr AI, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Zephyr AI, Inc. - overview

Established

2020

Location

McLean, VA, US

Primary Industry

Biotechnology

About

Based in Virginia, US, and founded in 2020 by co-founders Grant Verstandig, Yisroel Brumer, and Jeff Sherman, Zephyr AI, Inc. , aka Zephyr, operates as a provider of a platform based on AI that leverages enormous amounts of complicated data and unique algorithms to uncover new insights and possibilities in the healthcare vertical. In March 2024, Zephyr AI, Inc. raised USD 111 million in Series A funding from EPIQ Capital Group, Eli Lilly & Company Foundation, and Revolution Ventures.


The Series A funding valued Zephyr AI, Inc. at USD 387. 08 million post-money. As of April 2024, the company is led by its interim CEO, Jeff Sherman.


The firm offers a platform that transforms heterogeneous data into useful information that has applications in drug development, repurposing and rescue, clinical trial design and support, precision treatment recommendations, disease prevention, and others. The business intends to use the March 2024 funding for the expansion of analytical capabilities, data collection enrichment, and team growth acceleration.


Current Investors

MedStar Health Pension Fund, BoxGroup, AME Cloud Ventures

Primary Industry

Biotechnology

Sub Industries

Bioinformatics

Website

www.zephyrai.bio/

Verticals

Artificial Intelligence

Company Stage

Series A

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.